About Sumant Ramachandra
Form D filings for ImmPACT Bio USA from 2022 to 2024 list Sumant Ramachandra as president and chief executive officer, director.
Sumant Ramachandra first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Sumant Ramachandra in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sumant Ramachandra works with at each company, as listed on that company's latest Form D.
ImmPACT Bio USA Inc. · Form D/A, Apr 2, 2024
YC
Yvonne Chen
Director
Erez Chimovits
Director
HL
Han Lee
Executive officer
MS
Michal Silverberg
Director
XC
Xiangmin Cui
Director
SG
Sheila Guirathi
Director
YY
Yvonne Yamanaka
Director
CX
Cindy Xiong
Director